Safety And Efficacy Of Oral PF-4136309 In Patients With Chronic Hepatitis C Infection And Abnormal Liver Enzymes

NCT01226797 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
24
Enrollment
INDUSTRY
Sponsor class

Stopped See termination reason in detailed description.

Conditions

Interventions

Sponsor

Pfizer